ELVINA® is suitable for use in the following patient groups:⁵-⁶
References:
1. Elvina® SmPC
2. Yasmin® SmPC
available at www.medicines.ie
3. MIMS Ireland (August 2017) 'Contraception' MPI Media Ltd, Dublin.
4. Krattenmacher, R. 2000 Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception. 2000 Jul;62(1):29-38.
5. WHO Guidelines. Medical Eligibility Criteria for contraceptive use 2015 update.
6. Faculty of Sexual and Reproductive Health Care (FSRH). UK Medical Eligibility Criteria for Contraceptive Use. UKMEC 2016. London: FSRH, 2016.